Skip to main content
Elif Oral, MD, Endocrinology, Ann Arbor, MI

Elif Oral MD

Diabetes, Lipid Metabolism


Endocrinologist, Metabolism Endocrinology Diabetes & Podiatry Clinic

Join to View Full Profile
  • 24 Frank Lloyd Wright DrLobby C Suite 1300Ann Arbor, MI 48105

  • Phone+1 734-998-2450

Dr. Oral is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1996 - 1999
  • Detroit Medical Center/Wayne State University
    Detroit Medical Center/Wayne State UniversityResidency, Internal Medicine, 1993 - 1996
  • Istanbul University Fom
    Istanbul University FomClass of 1992

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2002 - 2027
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Fellow (FACE) American Association of Clinical Endocrinology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Metabolic Parameters, Weight Loss, and Comorbidities 4 Years After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy  
    Elif A Oral, Nazanene H Esfandiari, Colleen M Buda, Corey J Lager, Oliver A Varban, Andrew T Kraftson, Obesity Surgery

Press Mentions

  • New Potential Therapy for Fatty Liver Disease
    New Potential Therapy for Fatty Liver DiseaseJune 7th, 2021
  • Gemphire Announces Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLD
    Gemphire Announces Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLDAugust 10th, 2018
  • Michigan Medicine's Division of Metabolism, Endocrinology and Diabetes Showcases New Research at Endocrine Society's ENDO 2018
    Michigan Medicine's Division of Metabolism, Endocrinology and Diabetes Showcases New Research at Endocrine Society's ENDO 2018March 17th, 2018
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: